Functional analysis of a complement polymorphism (rs17611) associated with rheumatoid arthritis

Journal of Immunology

Volumn 194, Issue 7, 2015, Pages 3029-3034

  Giles, Joanna L ^a   Choy, Ernest ^a   Van Den Berg, Carmen ^a   Morgan, B Paul ^a   Harris, Claire L ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; LEUKOCYTE ELASTASE; COMPLEMENT;

ALLELE; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT COMPONENT C5 GENE; CONTROLLED STUDY; COPY NUMBER VARIATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; PROTEIN METABOLISM; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; CYTOTOXICITY; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HYDROLYSIS; IMMUNOLOGY; METABOLISM;

ALLELES; ARTHRITIS, RHEUMATOID; COMPLEMENT ACTIVATION; COMPLEMENT C5; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; HYDROLYSIS; LEUKOCYTE ELASTASE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84925858486     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402956     Document Type: Article

References (42)

1. Silman, A. J., and M. C. Hochberg. 1993. Epidemiology of the rheumatic diseases. Oxford University Press, New York, Vol. 504, p. 31-71.
2. Tobón, G. J., P. Youinou, and A. Saraux. 2010. The environment, geoepidemiology, and autoimmune disease: Rheumatoid arthritis. J. Autoimmun. 35: 10-14.
3. Barton, A., W. Thomson, X. Ke, S. Eyre, A. Hinks, J. Bowes, D. Plant, L. J. Gibbons, A. G. Wilson, D. E. Bax, et al. 2008. Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. Nat. Genet. 40: 1156-1159.
4. Kurreeman, F. A., L. Padyukov, R. B. Marques, S. J. Schrodi, M. Seddighzadeh, G. Stoeken-Rijsbergen, A. H. van der Helm-van Mil, C. F. Allaart, W. Verduyn, J. Houwing-Duistermaat, et al. 2007. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med. 4: e278.
5. Thomson, W., A. Barton, X. Ke, S. Eyre, A. Hinks, J. Bowes, R. Donn, D. Symmons, S. Hider, I. N. Bruce, et al. 2007. Rheumatoid arthritis association at 6q23. Nat. Genet. 39: 1431-1433.
6. Stahl, E. A., S. Raychaudhuri, E. F. Remmers, G. Xie, S. Eyre, B. P. Thomson, Y. Li, F. A. Kurreeman, A. Zhernakova, A. Hinks, et al. 2010. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42: 508-514.
7. Morgan, B. P. 2000. The complement system: an overview. Methods Mol. Biol. 150: 1-13.
8. Walport, M. J. 2001. Complement: first of two parts. N. Engl. J. Med. 344: 1058-1066.
9. Walport, M. J. 2001. Complement: second of two parts. N. Engl. J. Med. 344: 1140-1144.
10. Okroj, M., D. Heinegård, R. Holmdahl, and A. M. Blom. 2007. Rheumatoid arthritis and the complement system. Ann. Med. 39: 517-530.
11. Morgan, B. P., R. H. Daniels, and B. D. Williams. 1988. Measurement of terminal complement complexes in rheumatoid arthritis. Clin. Exp. Immunol. 73: 473-478.
12. Hedberg, H. 1964. The depressed synovial complement activity in adult and juvenile rheumatoid arthritis. Acta Rheumatol. Scand. 10: 109-127.
13. Kemp, P. A., J. H. Spragg, J. C. Brown, B. P. Morgan, C. A. Gunn, and P. W. Taylor. 1992. Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies. J. Clin. Lab. Immunol. 37: 147-162.
14. Wang, Y., S. A. Rollins, J. A. Madri, and L. A. Matis. 1995. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc. Natl. Acad. Sci. USA 92: 8955-8959.
15. Macor, P., P. Durigutto, L. De Maso, C. Garrovo, S. Biffi, A. Cortini, F. Fischetti, D. Sblattero, C. Pitzalis, R. Marzari, and F. Tedesco. 2012. Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. Arthritis Rheum. 64: 2559-2567.
16. Hietala, M. A., I. M. Jonsson, A. Tarkowski, S. Kleinau, and M. Pekna. 2002. Complement deficiency ameliorates collagen-induced arthritis in mice. J. Immunol. 169: 454-459.
17. Harris, C. L., M. Heurich, S. Rodriguez de Cordoba, and B. P. Morgan. 2012. The complotype: dictating risk for inflammation and infection. Trends Immunol. 33: 513-521.
18. Heurich, M., R. Martínez-Barricarte, N. J. Francis, D. L. Roberts, S. Rodríguez de Córdoba, B. P. Morgan, and C. L. Harris. 2011. Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk. Proc. Natl. Acad. Sci. USA 108: 8761-8766.
19. Kurreeman, F. A., G. N. Goulielmos, B. Z. Alizadeh, B. Rueda, J. Houwing-Duistermaat, E. Sanchez, M. Bevova, T. R. Radstake, M. C. Vonk, E. Galanakis, et al. 2010. The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases. Ann. Rheum. Dis. 69: 696-699.
20. Plenge, R. M., M. Seielstad, L. Padyukov, A. T. Lee, E. F. Remmers, B. Ding, A. Liew, H. Khalili, A. Chandrasekaran, L. R. Davies, et al. 2007. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N. Engl. J. Med. 357: 1199-1209.
21. Chai, L., Y. Q. Song, K. Y. Zee, and W. K. Leung. 2010. Single nucleotide polymorphisms of complement component 5 and periodontitis. J. Periodontal Res. 45: 301-308.
22. Woehrl, B., M. C. Brouwer, C. Murr, S. G. Heckenberg, F. Baas, H. W. Pfister, A. H. Zwinderman, B. P. Morgan, S. R. Barnum, A. van der Ende, et al. 2011. Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis. J. Clin. Invest. 121: 3943-3953.
23. Hoke, M., W. Speidl, M. Schillinger, E. Minar, S. Zehetmayer, M. Schönherr, O. Wagner, and C. Mannhalter. 2012. Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis. Eur. J. Clin. Invest. 42: 921-926.
24. Greisenegger, S., S. Zehetmayer, P. Bauer, G. Endler, J. Ferrari, W. Lang, M. Janisiw, L. Steiner, S. Cheng, W. Lalouschek, and C. Mannhalter. 2009. Polymorphisms in inflammatory genes and the risk of ischemic stroke and transient ischemic attack: results of a multilocus genotyping assay. Clin. Chem. 55: 134-138.
25. Aletaha, D., T. Neogi, A. J. Silman, J. Funovits, D. T. Felson, C. O. Bingham, III, N. S. Birnbaum, G. R. Burmester, V. P. Bykerk, M. D. Cohen, et al. 2010. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62: 2569-2581.
26. Harris, C. L., A. S. Williams, S. M. Linton, and B. P. Morgan. 2002. Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivo. Clin. Exp. Immunol. 129: 198-207.
27. Tortajada, A., T. Montes, R. Martínez-Barricarte, B. P. Morgan, C. L. Harris, and S. R. de Córdoba. 2009. The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity. Hum. Mol. Genet. 18: 3452-3461.
28. Montes, T., A. Tortajada, B. P. Morgan, S. Rodríguez de Córdoba, and C. L. Harris. 2009. Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B. Proc. Natl. Acad. Sci. USA 106: 4366-4371.
29. Fu, Q., P. McPhie, and D. C. Gowda. 1998. Methionine modification impairs the C5-cleavage function of cobra venom factor-dependent C3/C5 convertase. Biochem. Mol. Biol. Int. 45: 133-144.
30. van den Berg, C. W., R. M. Gonc¸alves-de-Andrade, C. K. Okamoto, and D. V. Tambourgi. 2012. C5a receptor is cleaved by metalloproteases induced by sphingomyelinase D from Loxosceles spider venom. Immunobiology 217: 935-941.
31. 2+ and oxidase activation in rat neutrophils. Cell Calcium 9: 17-26.
32. Vogt, W. 2000. Cleavage of the fifth component of complement and generation of a functionally active C5b6-like complex by human leukocyte elastase. Immunobiology 201: 470-477.
33. Pangburn, M. K., and N. Rawal. 2002. Structure and function of complement C5 convertase enzymes. Biochem. Soc. Trans. 30: 1006-1010.
34. Hadders, M. A., D. Bubeck, P. Roversi, S. Hakobyan, F. Forneris, B. P. Morgan, M. K. Pangburn, O. Llorca, S. M. Lea, and P. Gros. 2012. Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. Cell Reports 1: 200-207.
35. Mikes, B., G. Sinkovits, P. Farkas, D. Csuka, A. Schlammadinger, K. Rázsó, J. Demeter, G. Domján, M. Réti, and Z. Prohászka. 2014. Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura. Thromb. Res. 133: 616-621.
36. Nakano, S., T. Ikata, I. Kinoshita, J. Kanematsu, and S. Yasuoka. 1999. Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin. Exp. Rheumatol. 17: 161-170.
37. Bazzichi, L., M. L. Ciompi, L. Betti, A. Rossi, D. Melchiorre, M. Fiorini, G. Giannaccini, and A. Lucacchini. 2002. Impaired glutathione reductase activity and levels of collagenase and elastase in synovial fluid in rheumatoid arthritis. Clin. Exp. Rheumatol. 20: 761-766.
38. Döring, G. 1994. The role of neutrophil elastase in chronic inflammation. Am. J. Respir. Crit. Care Med. 150: S114-S117.
39. Tremblay, G. M., M. F. Janelle, and Y. Bourbonnais. 2003. Anti-inflammatory activity of neutrophil elastase inhibitors. Curr. Opin. Investig. Drugs 4: 556-565.
40. Miyoshi, S., H. Hamada, R. Ito, H. Katayama, K. Irifune, T. Suwaki, N. Nakanishi, T. Kanematsu, K. Dote, M. Aibiki, et al. 2013. Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis. Drug Des Devel Ther 7: 305-316.
41. Kakimoto, K., A. Matsukawa, M. Yoshinaga, and H. Nakamura. 1995. Suppressive effect of a neutrophil elastase inhibitor on the development of collagen-induced arthritis. Cell. Immunol. 165: 26-32.
42. Morgan, M., A. C. Bulmer, T. M. Woodruff, L. M. Proctor, H. M. Williams, S. Z. Stocks, S. Pollitt, S. M. Taylor, and I. A. Shiels. 2008. Pharmacokinetics of a C5a receptor antagonist in the rat after different sites of enteral administration. Eur. J. Pharm. Sci. 33: 390-398.